Mike Woelflein is a business and personal finance freelance writer. A former senior industry specialist with Standard & Poor's and managing editor of ColoradoBiz magazine, he has also written for The Denver Post and American Express.
Unbiased. Uncensored. That's how insider Adam Feuerstein gives you his take on what's hot and what's not in
biotech. You'll get the top picks on his subscriber-only Recommended List — stocks he believes, only after extensive research, have the potential for outsized returns even in this risky sector.